Insider Transactions Reported by 15 Insiders of Evommune, Inc.

Symbol
EVMN on NYSE
Location
Palo Alto, CA

Insiders trading volume in the past year

Evommune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert Lorne Hopfner Director, 10%+ Owner $65,644,323 +$17,350 +0.03% 19 Dec 2025
Luis C. Pena President & CEO, Director $11,679,544 09 Dec 2025
Eugene Bauer Chief Medical Officer, Director $4,831,393 09 Dec 2025
Janice Suzann Drew EVP, Operations $1,209,444 09 Dec 2025
Gregory S. Moss Chief Business & Legal Officer $1,144,827 09 Dec 2025
Kyle Carver Chief Financial Officer $1,115,178 09 Dec 2025
Jeegar Pravinkumar Patel Chief Scientific Officer $884,471 09 Dec 2025
Felice Isabel Verduyn-van Weegen Director, 10%+ Owner 07 Nov 2025
Derek DiRocco Director 05 Nov 2025
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner 07 Nov 2025
BENJAMIN F. MCGRAW III Director 05 Nov 2025
ARTHUR S. KIRSCH Director 05 Nov 2025
Pivotal bioVenture Partners Fund I, L.P. Director, 10%+ Owner 07 Nov 2025
David E. Cohen Director 07 Nov 2025
LSP 7 Cooperative UA 10%+ Owner 07 Nov 2025

Recent Insider Transactions by Companies or Individuals for Evommune, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.